아카디아 파마슈티컬스(ACADIA Pharmaceuticals Inc.)
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership2,251,978 shares
Ownership 1.60%
Point72 Asset Management, L.P. ownership in ACAD / ACADIA Pharmaceuticals Inc.

2019-02-14 - Point72 Asset Management, L.P. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,251,978 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD). This represents 1.6 percent ownership of the company. In their previous filing dated 2018-06-18 , Point72 Asset Management, L.P. had reported owning 6,521,566 shares, indicating a decrease of -65.47 percent.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 13,700 of underlying shares valued at $304,962 USD and put options representing 13,700 of underlying shares valued at $304,962 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2019-02-14 2019-02-14 13G/A 6,521,566 2,251,978 -65.47 1.60 -69.23
2018-06-18 2018-06-18 13G 6,521,566 5.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,577,916 -799,395 -23.67 57,384 -36.39 0.0735
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,377,311 1,890,954 127.22 90,208 184.40 0.1009
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,486,357 -1,686,154 -53.15 31,719 -53.65 0.0531
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,172,511 -1,475,305 -31.74 68,431 -11.36 0.1343
2025-07-21 2025-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 4,647,816 2,417,001 108.35 77,200 88.59 0.1762
2025-05-15 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,647,816 2,417,001 77,200 0.1762
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,230,815 2,230,815 40,935 0.0902
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -3,710,140 -100.00 0 -100.00
2024-09-16 2024-06-30 13F/A-2 ACADIA PHARMACEUTICALS COM 004225108 3,710,140 2,933,440 377.68 60,290 319.81 0.1578
2024-08-19 2024-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 3,710,140 2,933,440 60,290 0.1578
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,710,140 2,933,440 60,290 0.1576
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 776,700 383,873 97.72 14,361 16.77 0.0348
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 392,827 342,184 675.68 12,299 1,065.78 0.0297
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 50,643 -841,283 -94.32 1,055 -95.06 0.0031
2023-08-14 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 891,926 232,420 35.24 21,362 72.11 0.0635
2023-05-15 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 659,506 -456,394 -40.90 12,412 -30.14 0.0384
2023-05-15 2022-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,115,900 1,115,900 17,765 0.0604
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,115,900 1,115,900 17,765 0.0604
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -167,100 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 167,100 -411,095 -71.10 8,933 -62.55 0.0436
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 578,195 379,685 191.27 23,851 147.88 0.1221
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 198,510 198,510 9,622 0.0628
2020-05-15 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -671,009 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 671,009 671,009 28,706 0.1509
2019-11-15 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -1,600 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,600 -389,928 -99.59 43 -99.59 0.0002
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 391,528 -1,855,072 -82.57 10,513 -71.06 0.0477
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,246,600 439,600 24.33 36,328 -3.16 0.1774
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,807,000 -1,287,501 -41.61 37,513 -20.61 0.1547
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,094,501 -1,262,925 -28.98 47,253 -51.74 0.1886
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,357,426 1,961,328 81.86 97,911 35.71 0.4093
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,396,098 1,670,898 230.41 72,147 164.10 0.3114
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 725,200 -680,822 -48.42 27,318 -30.34 0.1219
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,406,022 -525,178 -27.19 39,214 -40.94 0.2200
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,931,200 706,200 57.65 66,395 87.93 0.3700
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,225,000 -846,500 -40.86 35,329 -46.39 0.2470
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,071,500 871,800 72.67 65,894 69.21 0.4633
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,199,700 -1,023,000 -46.03 38,942 -37.34 0.2650
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,222,700 1,918,900 631.63 62,147 473.84 0.4768
2016-02-16 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 303,800 -1,708,200 -84.90 10,830 -83.72 0.0893
2015-11-16 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,012,000 664,744 49.34 66,537 17.93 0.5223
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,347,256 -900,044 -40.05 56,423 -22.96 0.3908
2015-05-15 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,247,300 1,228,700 120.63 73,240 126.46 0.4992
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,018,600 93,600 10.12 32,341 41.21 0.2269
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 925,000 -157,000 -14.51 22,903 -6.30 0.1724
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,082,000 1,082,000 24,442 0.1567
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM Call 13,700 305 n/a n/a n/a
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-09-16 2024-06-30 13F/A ACADIA PHARMACEUTICALS COM Call 102,000 13.33 1,658 -0.42 n/a n/a n/a
2024-08-19 2024-06-30 13F/A ACADIA PHARMACEUTICALS COM Call 102,000 1,658 n/a n/a n/a
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Call 102,000 1,658 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Call 90,000 1,664 n/a n/a n/a
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM Call 198,900 5,132 n/a n/a n/a
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM Call 200,000 -90.48 4,152 -87.05 n/a n/a n/a
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM Call 2,100,000 32,067 n/a n/a n/a
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM Call 120,300 3,827 n/a n/a n/a
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS CALL Call 450,000 12,582 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM Put 13,700 305 n/a n/a n/a
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM Put 400,000 8,988 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM Put 500,000 18,835 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.